Resveratrol attenuates left ventricular remodeling in old rats with COPD induced by cigarette smoke exposure and LPS instillation (Q42708154)

5 November 2017

Resveratrol attenuates left ventricular remodeling in old rats with COPD induced by cigarette smoke exposure and LPS instillation (English)

1 reference

chronic obstructive pulmonary disease

5 November 2017

1 reference

based on heuristic

inferred from title

ventricular remodeling

1 reference

Yi Xin Hu

1

1 reference

5 November 2017

Hua Cui

2

1 reference

5 November 2017

Li Fan

3

1 reference

5 November 2017

Xiu Jie Pan

4

1 reference

5 November 2017

Ji Hua Wu

5

1 reference

5 November 2017

Suo Zhu Shi

6

1 reference

5 November 2017

Shao Yuan Cui

7

1 reference

5 November 2017

Zhi Min Wei

8

1 reference

5 November 2017

Lin Liu

9

1 reference

5 November 2017

30 July 2013

1 reference

Canadian Journal of Physiology and Pharmacology

5 November 2017

1 reference

5 November 2017

91

1 reference

5 November 2017

12

1 reference

5 November 2017

1044-1054

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

5 November 2017

1 reference

Sirt1 regulates aging and resistance to oxidative stress in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

The pathophysiology of cigarette smoking and cardiovascular disease: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Differential sensitivity to LPS-induced myocardial dysfunction in the isolated brown Norway and Dahl S rat hearts: roles of mitochondrial function, NF-κB activation, and TNF-α production

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Molecular and biochemical changes of the cardiovascular system due to smoking exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Percent emphysema, airflow obstruction, and impaired left ventricular filling

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Prevalence of comorbidities in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Resveratrol protects cardiomyocytes from hypoxia-induced apoptosis through the SIRT1-FoxO1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Testing drugs in animal models of cigarette smoke-induced chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Increased resistance to LPS-induced myocardial dysfunction in the Brown Norway rats versus Dahl S rats: roles of inflammatory cytokines and nuclear factor kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

The role of oxidative stress and lipid peroxidation in ventricular remodeling induced by tobacco smoke exposure after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Fibroblast apoptosis precedes cardiomyocyte mass reduction during left ventricular remodeling in hypertensive rats treated with amlodipine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Resveratrol causes cell cycle arrest, decreased collagen synthesis, and apoptosis in rat intestinal smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

The delivery of prevention programmes for cardiovascular disease and chronic obstructive pulmonary disease in Lodz by primary care physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kappaB and inflammatory activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Sirt1 protects the heart from aging and stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Development of Bacteroides 16S rRNA gene TaqMan-based real-time PCR assays for estimation of total, human, and bovine fecal pollution in water

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Cardiovascular effects and molecular targets of resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Global burden of COPD: risk factors, prevalence, and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Resveratrol protects adult cardiomyocytes against oxidative stress mediated cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Acute effects of different levels of continuous positive airway pressure on cardiac autonomic modulation in chronic heart failure and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Dietary resveratrol administration increases MnSOD expression and activity in mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear Sirt1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Cytokine-induced nitric oxide inhibits mitochondrial energy production and induces myocardial dysfunction in endotoxin-treated rat hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Resveratrol prevents norepinephrine induced hypertrophy in adult rat cardiomyocytes, by activating NO-AMPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Mitochondrial oxidative stress and dysfunction in myocardial remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Resveratrol in cardiovascular disease: what is known from current research?

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Antioxidant and anti-inflammatory effects of resveratrol in airway disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Animal models of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: implications for chronic inflammation and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Beta-carotene supplementation attenuates cardiac remodeling induced by one-month tobacco-smoke exposure in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1139%2FCJPP-2012-0464

21 January 2018

Identifiers

DOI

10.1139/CJPP-2012-0464

1 reference

5 November 2017

1 reference